NCT07616999 A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse Status NOT_YET_RECRUITING Phase N/A
NCT07615426 A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia Status RECRUITING Phase PHASE1
NCT07615075 Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With Schizophrenia Status NOT_YET_RECRUITING Phase PHASE4
NCT07609953 Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia Status COMPLETED Phase NA
NCT07604129 Transcranial Sonography and Machine Learning for Schizophrenia Identification Status NOT_YET_RECRUITING Phase N/A
NCT07592884 Rochester Forensic Assertive Community Treatment Model in Minnesota Status COMPLETED Phase NA
NCT07586150 Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN) Status NOT_YET_RECRUITING Phase NA
NCT07585383 A Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of KR23248 Capsules in Healthy Adult Subjects Status NOT_YET_RECRUITING Phase PHASE1
NCT07571148 Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07557381 The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients Status RECRUITING Phase NA
NCT07557368 Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia Status RECRUITING Phase NA
NCT07549581 A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode Status COMPLETED Phase PHASE1
NCT07547384 Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia. Status NOT_YET_RECRUITING Phase NA
NCT07534475 Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT Status NOT_YET_RECRUITING Phase NA
NCT07523256 Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia Status COMPLETED Phase NA
NCT07484204 Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia Status NOT_YET_RECRUITING Phase PHASE1
NCT07479758 Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders Status RECRUITING Phase N/A
NCT07477301 Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in Schizophrenia Status COMPLETED Phase PHASE2